Enstilar in Combination With Biologic Agents

NCT03080545 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Enstilar 0.005%-0.064% Topical Foam

Sponsor

Psoriasis Treatment Center of Central New Jersey

Collaborators

[object Object]